Hims & Hers News and Activities

Hims & Hers is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Hims & Hers is a company listed under the stock ticker HIMS (US).

Hims & Hers has a direct presence in 2 countries.

They are in:

• Pharmaceuticals33%
• Healthcare33%
• Other33%

Acquisition, funding and merger involving Hims & Hers.

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Hims & Hers has just announced a $350 Million fundraising (posted on May 22 2026).
• Hims & Hers has announced the acquisition of Eucalyptus  (posted on February 20 2026).
• Hims & Hers has announced the acquisition of YourBio Health  (posted on December 5 2025).
• See more news about Hims & Hers Hide news involving Hims & Hers

View the org chart displaying its 75 main executives

Most searched biographies at Hims & Hers

• Andrew Dudum, Director and Chief Executive Officer
• Kåre Schultz, Director
• Andrea Perez, Director

Popular executive movements at Hims & Hers

• Kathryn Beiser has joined the company as Chief Communications Officer  (posted on March 11 2026).
• Deb Autor who was Director, becomes Chief Policy Officer  (posted on November 18 2025).
• Gordon Griffith has joined the company as Senior Vice President, Strategic Finance  (posted on October 8 2025).

Click here to view some more movements at Hims & Hers

Create your alert
to follow the executive moves at Hims & Hers.

Hims & Hers has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Hims & Hers

• Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
• Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
• Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
• Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
• Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
• Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
• Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
• Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
• Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
• Hims & Hers Names Kathryn Beiser as Chief Communications Officer
• View more press releases Close

Social media about Hims & Hers

• Hims & Hers on Wikipedia, Google News & Yahoo Finance
• Hims & Hers on LinkedIn, X (Twitter) & YouTube